New Director's Experience a Plus for MSU, but his Controversial Views Concern Some
By Matthew Miller,
Lansing State Journal
| 10. 06. 2012
Stephen Hsu was an unconventional choice to lead Michigan State University’s research enterprise.
A theoretical physicist by training, Hsu has done respected work on dark energy, black holes and the more esoteric reaches of particle physics, but his only experience in academic administration was a stint last year as the director of the University of Oregon’s Institute for Theoretical Science. The institute’s budget that year was just shy of $74,000.
As vice president for research and graduate studies at MSU, the position he assumed in August, Hsu is charged with setting the broad direction and expectations for a research operation that topped $400 million in expenditures in 2010. His office administers millions in internal grant money, ensures the university’s compliance with ethical and legal standards for research, leads MSU’s efforts to commercialize its research.
But Hsu has another sort of experience that MSU’s leaders found compelling: years as a Silicon Valley entrepreneur, and a successful one at that.
MSU President Lou Anna Simon said Hsu is not only “an extraordinary intellect,” but he “understands the relationship of research to economic...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
By Grace Won, KQED Forum [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...